Therefore, liver-specific Rab2A knockout models are needed to further delineate the in vivo functions of Rab2A in regulation of hepatic lipid metabolism and in the pathogenesis of NAFLD in the future. The gene discussed is RAB2A; the disease is metabolic dysfunction-associated steatotic liver disease.